We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Which Is Your Best Bet On Africa: Old Mutual plc, Hikma Pharmaceuticals Plc Or PZ Cussons plc?

G A Chester puts Africa growth-story bets Old Mutual plc (LON:OML), Hikma Pharmaceuticals Plc (LON:HIK) and PZ Cussons plc (LON:PZC) under the spotlight.

| More on:

You’re reading a free article with opinions that may differ from The Twelfth Magpie’s Premium Investing Services. Become a member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more, and get a free 'Best Buy Now' stock!.

As the world industrialises, Africa remains the last continent with the greatest latent potential for growth. If you’re interested in tapping into this potential, UK-listed companies Old Mutual (LSE: OML), Hikma Pharmaceuticals (LSE: HIK) and PZ Cussons (LSE: PZC) all have substantial exposure to African markets.

Old Mutual

Established in South Africa in 1845, Old Mutual is an investment, savings, insurance and banking group. The company is a member of the FTSE 100.

Should you buy Hikma Pharmaceuticals Plc shares today?

Before you decide, please take a moment to review this report first. Despite ongoing uncertainties from US tariffs to global conflicts, Mark Rogers and his team believe many UK shares still trade at substantial discounts, offering savvy investors plenty of potential opportunities to learn about.

That’s why this could be an ideal time to secure this valuable research – Mark’s analysts have scoured the markets to reveal 5 of his favourite long-term ‘Buys’. Please, don’t make any big decisions before seeing them.

In 2014, 68% of Old Mutual’s revenue was earned in Southern Africa, while 25% came from the UK, which is the group’s second-largest market. Within the Southern Africa region, South Africa dominates, but Old Mutual continues to extend its reach beyond its historic homeland, as it seeks to become “an African financial services champion”.

Old Mutual trades on a current-year forward P/E of 11.5, falling to 10.5 next year. With forward earnings growth per annum expected to run at around 10% (and to support strong dividend growth from a starting yield of 4.3%), the shares seem to offer good value.

Hikma Pharmaceuticals

Founded in 1978 by a Palestinian-born former marketing manager of US drugs heavyweight Eli Lilly, Hikma Pharmaceuticals’ growth has been impressive; in fact, so much so that the company has just been promoted to the FTSE 100.

The US is Hikma’s biggest market by revenue (51%), but the company also earns substantial revenue from the Middle East and North Africa (43%). Hikma’s North African markets extend all the way from Morocco across to Egypt, and down the Red Sea to Sudan and Somalia.

Hikma posted 9% revenue and earnings growth for 2015, but analysts are expecting a more subdued 2015, partly because of currency exchange rates. Hikma trades on a forecast P/E of about 23, with a dividend yield of less than 1%. On the face of it, not particularly good value, but the company does have the resources to make earnings-enhancing acquisitions (as it has in the past).

PZ Cussons

The origins of FTSE 250 firm PZ Cussons can be traced back to a trading post set up in Sierra Leone in 1884. The personal care, home care and foods group continues to maintain a strong presence in Africa, centred on Nigeria, Ghana and Kenya. Revenue by geographical region breaks down as: Africa 40%, Europe 34% and Asia 26%.

Investing for African growth is a long-term affair, and recent events in and around Cussons’ biggest single market — Nigeria — highlight the turbulence that can be expected along the way. The Ebola outbreak, disruption by violent Islamist movement Boko Haram and a devaluation of the Naira are all currently impacting on Cussons’ overall group performance.

Analysts are forecasting a modest decline in earnings for the company’s fiscal year ending 31 May. However, they also expect a return to high single-digit/low double-digit growth for the year to May 2016, putting Cussons on a P/E of 18 with a dividend yield of 2.5%. This seems reasonable value against peers in the highly-rated consumer goods sector.

Companies with powerful brands — such as Cussons — are among my personal favourites as buy-and-hold investments. But it occurs to me that Old Mutual (with its strength in Southern Africa), Hikma (with its North African markets) and Cussons (with its focus on West and East Africa) together offer exposure to different growth themes across the continent that could all pay off in the long term.

G A Chester has no position in any shares mentioned. The Motley Fool UK owns shares of PZ Cussons. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Shot of an young mixed-race woman using her cellphone while out cycling through the city
Investing Articles

2 FTSE 100 bargain stocks to buy in June?

Searching for the best value stocks to buy? Royston Wild reveals two trading on rock-bottom valuations -- including a popular…

Read more »

Illustration of flames over a black background
Investing Articles

Hot, hotter, hottest. Is it too late to consider these 3 FTSE 100 shares?

James Beard looks at the three best- performing FTSE 100 stocks over the past year. But are they still worth…

Read more »

Young female analyst working at her desk in the office
Investing Articles

The only FTSE 100 stock I own right now

Muhammad Cheema reveals the only share he owns in the FTSE 100. However, that doesn’t mean he’s not a fan…

Read more »

Investing Articles

Are Greggs shares about to go gangbusters all over again?

Greggs shares have been showing signs of renewed life and Harvey Jones examines whether the battered FTSE 250 bakery chain…

Read more »

Businessman hand stacking money coins with virtual percentage icons
Investing Articles

4,898 shares in British American Tobacco return £12,000 a year in dividends. Worth it?

A falling share price means a higher dividend yield for British American Tobacco shares. Should passive income investors take a…

Read more »

A handsome mature bald bearded black man in a sunglasses and a fashionable blue or teal costume with a tie is standing in front of a wall made of striped wooden timbers and fastening a suit button
Growth Shares

As it swallows up more firms, this penny stock looks primed to head higher

Jon Smith reviews a penny stock that has caught his attention, with its acquisition strategy proving to help increase the…

Read more »

Array of piggy banks in saturated colours on high colour contrast background
Investing Articles

£5,000 invested in HSBC shares in an ISA 5 years ago is now worth…

HSBC has made for a stunning investment. Andrew Mackie assesses whether new ISA investors could still see similar returns over…

Read more »

Two female adult friends walking through the city streets at Christmas. They are talking and smiling as they do some Christmas shopping.
Investing Articles

This UK income stock yields an eye-popping 7.3% but can it afford to keep growing its dividend?

Harvey Jones examines an income stock with a sky-high yield, because he wants to be sure it can keep the…

Read more »